Novavax COVID-19 vaccine could gain European, WHO approval next week - FT


FILE PHOTO: FILE PHOTO: A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic

(Reuters) - The European Medicines Agency could approve the Novavax coronavirus vaccine as early as next week, paving the way for emergency use listing from the World Health Organization, the Financial Times reported on Thursday, citing sources.

Novavax shares rose 7% after the report.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

Microsoft's quarterly revenue rises 19 pct, net income up 32 pct
Sichuan flavors bring Chinese culinary heritage to Oxford
U.S. stocks close higher as Fed holds rates steady
Flavio Bolsonaro declares himself "leader of Brazil" despite election defeat
Canada not in position yet to sign U.S. trade deal: Carney
Proposed Air Canada-United deal likely to harm market competition: regulator
Explainer: Two deadly crashes in nine months: What's happening to Spain's high-speed rail?
U.S. stocks close higher
Flavio Bolsonaro declares himself rightful president-elect of Brazil
Italy's cabinet approves 26-billion-euro budget for 2027

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read